Literature DB >> 1993180

Gene structure and chromosomal localization of plasma kallikrein.

G Beaubien1, I Rosinski-Chupin, M G Mattei, M Mbikay, M Chrétien, N G Seidah.   

Abstract

Plasma kallikrein (Fletcher factor) is a hepatic serine proteinase that participated in the early phase of blood coagulation. From two genomic libraries, we succeeded to isolate four overlapping clones representing the entire rat plasma kallikrein gene. Using selective DNA sequencing, polymerase chain reactions, and restriction mapping, we demonstrated that the gene for rat plasma kallikrein was 22 kb in length. Similar to human factor XI [Asakai et al. (1987) Biochemistry 26, 7221-7228], we also found that the plasma kallikrein gene is composed of 15 exons and 14 introns. A potential transcription initiation step was determined by a novel application of the polymerase chain reaction technique. Computer analysis of the 5'-promoter region of this gene revealed some putative control elements that might regulate the rat plasma kallikrein gene expression. These data and the results of chromosomal localization reported in the present study for mouse (chromosome 8) and human (chromosome 4) plasma kallikrein genes strongly corroborate a genic duplication event from a common ancestor to both plasma kallikren and factor XI.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1993180     DOI: 10.1021/bi00220a027

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

Review 1.  Mouse chromosome 8.

Authors:  J D Ceci; A J Lusis
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

2.  Investigational plasma kallikrein inhibitors for the treatment of diabetic macular edema: an expert assessment.

Authors:  Ashay D Bhatwadekar; Viral S Kansara; Thomas A Ciulla
Journal:  Expert Opin Investig Drugs       Date:  2020-01-31       Impact factor: 6.206

3.  The Ant1 gene maps near Klk3 on proximal mouse chromosome 8.

Authors:  K A Mills; J W Ellison; K D Mathews
Journal:  Mamm Genome       Date:  1996-09       Impact factor: 2.957

4.  International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors.

Authors:  Margarita L Dubocovich; Philippe Delagrange; Diana N Krause; David Sugden; Daniel P Cardinali; James Olcese
Journal:  Pharmacol Rev       Date:  2010-07-06       Impact factor: 25.468

5.  Common variation in KLKB1 and essential hypertension risk: tagging-SNP haplotype analysis in a case-control study.

Authors:  Xiangfeng Lu; Weiyan Zhao; Jianfeng Huang; Hongfan Li; Wei Yang; Laiyuan Wang; Wentao Huang; Shufeng Chen; Dongfeng Gu
Journal:  Hum Genet       Date:  2007-02-23       Impact factor: 4.132

6.  Genetic mapping near the myd locus on mouse chromosome 8.

Authors:  K A Mills; K D Mathews; T Scherpbier-Heddema; R L Schelper; R Schmalzel; H L Bailey; J H Nadeau; K H Buetow; J C Murray
Journal:  Mamm Genome       Date:  1995-04       Impact factor: 2.957

Review 7.  Human plasma kallikrein-kinin system: physiological and biochemical parameters.

Authors:  J W Bryant; Z Shariat-Madar
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2009-07

8.  Host envelope glycoprotein processing proteases are indispensable for entry into human cells by seasonal and highly pathogenic avian influenza viruses.

Authors:  Hiroshi Kido; Yuushi Okumura; Etsuhisa Takahashi; Hai-Yan Pan; Siye Wang; Junji Chida; Trong Quang Le; Mihiro Yano
Journal:  J Mol Genet Med       Date:  2008-11-29

9.  Proof-of-concept Studies for siRNA-mediated Gene Silencing for Coagulation Factors in Rat and Rabbit.

Authors:  Zhu Chen; Bin Luo; Tian-Quan Cai; Anil Thankappan; Yiming Xu; Weizhen Wu; Jillian DiMuzio; Traci Lifsted; Marty DiPietro; Jyoti Disa; Bruce Ng; Karen Leander; Seth Clark; Lizbeth Hoos; Yuchen Zhou; Nina Jochnowitz; Christine Jachec; Peter Szczerba; Marian E Gindy; Walter Strapps; Laura Sepp-Lorenzino; Dietmar A Seiffert; Laura Lubbers; Marija Tadin-Strapps
Journal:  Mol Ther Nucleic Acids       Date:  2015-01-27       Impact factor: 10.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.